the standard work-up provides the basis for staging of the patient and determining the treatment strategy. The first step is the decision in a multi-disciplinary meeting on whether surgery is required. Radiotherapy is the treatment of choice for small
Julie J. Willeumier, Yvette M. van der Linden, Michiel A.J. van de Sande, and P.D. Sander Dijkstra
Andrea Angelini, Nicolò Mosele, Elisa Pagliarini, and Pietro Ruggieri
. Radiotherapy and medical treatments Many treatments have been proposed since the first description of this disease. The results of the accurate systematic review of the literature were summarized in a diagnostic and treatment algorithm ( Fig. 5 ). Figure 5
Robert Grimer, Michael Parry, and Steven James
with an involved margin In the first two situations, re-excision has been successful and the only decision is whether further adjuvant therapy is needed. In most cases of a high-grade tumour, radiotherapy should be considered, especially for
Elisa Pala, Alberto Procura, Giulia Trovarelli, Antonio Berizzi, and Pietro Ruggieri
terms of (i) time of surgery and fluoroscopy exposure, (ii) incidence and types of complications, and (iii) response to radiotherapy (callus formation and local control of the disease). Materials and methods All oncologic patients treated with IM
Miklós Szendrői, Imre Antal, Attila Szendrői, Áron Lazáry, and Péter Pál Varga
bone. In the past, mostly palliative treatments, radiotherapy and pain relief were favoured. Nowadays, modern diagnostic tools (PET-CT, whole body MRI, etc) are included in the follow-up protocols allowing for early detection of bony metastases. Besides
Maria Anna Smolle, Dimosthenis Andreou, Per-Ulf Tunn, Joanna Szkandera, Bernadette Liegl-Atzwanger, and Andreas Leithner
high-grade STS is surgery, complemented by radiotherapy (RTX) and in selected cases chemotherapy (CTX). Surgery Over the last 30 years, amputation has progressively become less important and has been mostly replaced by limb-sparing procedures in
Olga D. Savvidou, Panagiotis Koutsouradis, George D. Chloros, Ioannis Papanastasiou, Thomas Sarlikiotis, Aggelos Kaspiris, and Panayiotis J. Papagelopoulos
-
Bone tumours around the elbow are rare. Even nowadays diagnostic dilemmas and delays are common. During recent decades the management and prognosis of patients with elbow bone tumours has improved significantly.
-
Benign tumours can be treated using minimally invasive procedures, whereas malignant ones require a multidisciplinary team approach based on an adjuvant therapeutic regimen of chemotherapy, radiotherapy and limb salvage procedures.
-
This article reviews the most commonly encountered elbow bone tumours and their management.
Cite this article: EFORT Open Rev 2019;4:133-142. DOI: 10.1302/2058-5241.4.180086
Elena Bravo, Raul Barco, and E. Carlos Rodríguez-Merchán
, and radiotherapy. Fibrin glue consists of two separate solutions of fibrinogen and thrombin, which, when mixed, mimic the final stages of the clotting cascade to form a fibrin clot. This clot may produce haemostasis and promote wound healing. 30
Maria Anna Smolle, Joanna Szkandera, Dimosthenis Andreou, Emanuela Palmerini, Marko Bergovec, and Andreas Leithner
), unresectable or metastatic tumours may be treated with standard radiotherapy (RTX), particle therapy, embolization or isolated limb perfusion (ILP). Treatment plans are discussed in multidisciplinary team meetings in order to achieve the best outcomes possible
Catalin Cirstoiu, Bogdan Cretu, Sergiu Iordache, Mihnea Popa, Bogdan Serban, and Adrian Cursaru
need for further surgery. Radiotherapy is the most commonly used treatment for bone metastases, but surgical treatment for preventive purposes in the pre-fracture stages, or even for curative purposes in the case of solitary metastases, is an important